Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-22

Clinical Trial Update: Short Bowel Syndrome and Teduglutide Versus Placebo [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing teduglutide to placebo in short bowel syndrome has completed and posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GATTEX (teduglutide)

Snippet

Sponsor: Mayo Clinic | Conditions: Short Bowel Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2016-02-22